Glucagon‐Like Peptide‐1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
- Journal:
- Arthritis & Rheumatology
- Published:
- DOI:
- 10.1002/art.43403
- Affiliations:
- 2
- Authors:
- 5
| Institutions | Authors | Share |
|---|---|---|
| Massachusetts General Hospital (MGH), United States of America (USA) | 0.70 | |
| Harvard Medical School (HMS), United States of America (USA) | 0.30 |